← FDA DRUG APPROVALS
FDA ANDA · ANDA214401
CLINDAMYCIN IN 5 PERCENT DEXTROSE
clindamycin in percent dextrose
Sponsor: HIKMA
APPLICATION
ANDA214401
TYPE
ANDA
ORIGINAL APPROVAL
2023-04-05
LATEST ACTION
2023-04-05
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%Prescription
CLINDAMYCIN PHOSPHATE EQ 18MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%Prescription
CLINDAMYCIN PHOSPHATE EQ 6MG BASE/ML · INJECTABLE · INJECTION
CLINDAMYCIN PHOSPHATE IN DEXTROSE 5%Prescription
CLINDAMYCIN PHOSPHATE EQ 12MG BASE/ML · INJECTABLE · INJECTION
Approval history
2023-04-05UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.